Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt.
Ayala G, Yan J, Li R, Ding Y, Thompson TC, Mims MP, Hayes TG, MacDonnell V, Lynch RG, Frolov A, Miles BJ, Wheeler TM, Harper JW, Tsai MJ, Ittmann MM, Kadmon D.
Ayala G, et al.
Clin Cancer Res. 2008 Nov 15;14(22):7511-8. doi: 10.1158/1078-0432.CCR-08-0839.
Clin Cancer Res. 2008.
PMID: 19010869
Free PMC article.
Clinical Trial.